Jaguar Health (JAGX) Retained Earnings (2014 - 2026)
Jaguar Health (JAGX) reported Retained Earnings of -$391.1 million for Q1 2026, down 55766.71% year-over-year from N/an in Q1 2025, and down 46846.82% quarter-over-quarter from -$833000.0 in Q4 2025.
Jaguar Health (JAGX) Retained Earnings (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Retained Earnings data on file, last reported at -$391.1 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$391.1 million, down 55766.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$391.1 million (down 55766.71% YoY), and the FY2025 annual result was -$833000.0, up 99.76% from the prior year.
- Retained Earnings retreated to -$391.1 million in Q1 2026 per JAGX's latest filing, from -$833000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at -$461000.0 in Q1 2024 and troughed at -$391.1 million in Q1 2026.
- A 5-year average of -$164.2 million and a median of -$237.5 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2026: Retained Earnings soared 99.81% in 2024, then sank 55766.71% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$680000.0 in 2022, then advanced by 4.12% to -$652000.0 in 2023, then plunged by 53041.41% to -$346.5 million in 2024, then surged by 99.76% to -$833000.0 in 2025, then slumped by 46846.82% to -$391.1 million in 2026.
- Business Quant data shows JAGX's Retained Earnings at -$391.1 million in Q1 2026, -$833000.0 in Q4 2025, and -$376.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -838.07 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | -391.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -391.07 Mn |
| Dec 31, 2025 | -833,000.00 |
| Sep 30, 2025 | -376.86 Mn |
| Jun 30, 2025 | -719,000.00 |
| Mar 31, 2025 | -700,000.00 |
| Dec 31, 2024 | -346.48 Mn |
| Sep 30, 2024 | -336.60 Mn |
| Jun 30, 2024 | -542,000.00 |
| Mar 31, 2024 | -461,000.00 |
| Dec 31, 2023 | -652,000.00 |
| Sep 30, 2023 | -299.10 Mn |
| Jun 30, 2023 | -291.30 Mn |
| Mar 31, 2023 | -884,000.00 |
| Dec 31, 2022 | -680,000.00 |
| Sep 30, 2022 | -259.40 Mn |
| Jun 30, 2022 | -246.85 Mn |
| Mar 31, 2022 | -237.48 Mn |
| Dec 31, 2021 | -219.49 Mn |
| Sep 30, 2021 | -205.18 Mn |
| Jun 30, 2021 | -193.00 Mn |